Commentary by Jacqueline Friedman, MD, Clinical Associate Professor of Neurology, Director, New York Region Veterans Administration Multiple Sclerosis Center of Excellence
Multiple sclerosis (MS), a chronic disease of the central nervous system, is thought …
Commentary By: Neil Shapiro, M.D. Editor-in-Chief Clinical Correlations
As summer winds down and the weather prematurely cools off, this weeks shortcuts finds us focusing on the genetics of coumadin treatment, the very controversial …
Commentary by Rosemary Adamson, PGY2, Deena Altman PGY-1 and Harold Horowitz, Professor of Medicine, Section of Infectious Diseases
Syphilis is back! You know the drill: an 80-something year old man presents with dementia …
Case Presentation By: Marshall Fordyce, Senior Chief Resident
Welcome to the monthly posting of our NYU Department of Medicine’s Clinical Pathology Conference. Use the links below to review the case and the …
Commentary by Helen Kourlas, PharmD
Beta-adrenergic receptor antagonists, commonly known as beta-blockers (B-blockers) have been used for decades to treat hypertension, ischemic heart disease and some arrhythmias – and more recently to treat …
Commentary By Sean Cavanaugh, M.D. Associate Editor, Clinical Correlations
With the ever-increasing public concern about drug safety, and the profusion of wave-making research into clinical endpoints, occasional very public collisions are inevitable. And so opens this week’s Shortcuts…
Two recent …
Commentary by Zackary Berger MD PhD, PGY-2
In the political arena, reforming health care is continually a major domestic issue. It’s no surprise that the lead 2008 democratic contenders cite the same statistic …
Commentary by Melissa Freeman MD, PGY2
Please also see Part I of this series
In 2002, the American Association of Clinical Endocrinologists (AACE), the American Thyroid Association (ATA), and The Endocrine Society (TES) sponsored an evidence- …